Job Recruitment Website - Zhaopincom - Guan Yuxiu's personal information introduction

Guan Yuxiu's personal information introduction

Guan Yuxiu, Chairman of Sunflower Pharmaceutical Group Co., Ltd.

Ms. Guan Yuxiu, born in 1979, holds a bachelor’s degree. He won the May 1st Labor Medal of Heilongjiang Province in 2011 and the Model Worker of Heilongjiang Province in 2012. He has been a member of the Wuchang CPPCC since 2011. He once served as the head of the advertising department, assistant to the financial director, provincial manager of Chongqing District, general manager of Sunflower Pharmaceutical Group (Yichun) Co., Ltd., and general manager of Sunflower Pharmaceutical Group (Tangshan) Biopharmaceutical Co., Ltd. of Heilongjiang Sunflower Pharmaceutical Co., Ltd. Director and general manager of Sunflower Group Co., Ltd.

Guan Yuxiu is currently the chairman of Sunflower Group Co., Ltd., the chairman and general manager of Heilongjiang Jinkui Investment Co., Ltd., and the chairman and general manager of Wuchang Sunflower Sunshine Rice Co., Ltd. Chairman of Sunflower Pharmaceutical Group Co., Ltd.

Introduction to Sunflower Pharmaceutical Group

Sunflower Pharmaceutical Group is a large national pharmaceutical enterprise group with 14 companies under its jurisdiction. It is a well-known pharmaceutical group in the national proprietary Chinese medicine industry and was formerly known as Heilongjiang Province. Sunflower Pharmaceutical Co., Ltd., after years of development, has become a well-known pharmaceutical brand throughout the country. The "Sunflower" trademark has been recognized as a "China Famous Trademark" by the country. At the same time, it has been widely recognized by the general public and among the masses. Enjoy a very high reputation in my mind.

After more than ten years of cultivation, Sunflower Pharmaceutical Group has developed from relying on only one production company and three leading products to develop into eight production companies, 6 major product series, and 15 dosage forms. The new production and marketing pattern of 718 "quasi" brand name drugs, including 5 protected traditional Chinese medicine varieties, 12 exclusive varieties, 346 drugs included in the medical insurance catalog, and 180 products included in the national essential drugs catalog. Now we have 7 sales divisions and a nationwide sales network, forming a modern marketing model with sunflower characteristics.